PF-Atlas › Mechanisms › Direct clearance of FAP+ activated myofibroblasts via chimeric antigen receptor T cells
Direct clearance of FAP+ activated myofibroblasts via chimeric antigen receptor T cells in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
Direct clearance of FAP+ activated myofibroblasts via chimeric antigen receptor T cells is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.
Drugs targeting Direct clearance of FAP+ activated myofibroblasts via chimeric antigen receptor T cells
Therapies
Medical disclaimer. This is a research summary, not medical advice.